Fri, Apr 26, 2024
[Archive]
Volume 2, Issue 3 (Aug 2017)
JNFS 2017, 2(3): 231-234 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Amani R, Sharifi N. Vitamin D: Is There a New Era?. JNFS 2017; 2 (3) :231-234
URL: http://jnfs.ssu.ac.ir/article-1-89-en.html
URL: http://jnfs.ssu.ac.ir/article-1-89-en.html
Food Security Research Center, Department. of Clinical Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Full-Text [PDF 212 kb]
(707 Downloads)
| Abstract (HTML) (3412 Views)
.PNG)
.PNG)
References
Full-Text: (563 Views)
Vitamin D: Is There a New Era?
Reza Amani; PhD, R Nutr*1 & Nasrin Sharifi; PhD2
1 Food Security Research Center, Department. of Clinical Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran.
Reza Amani; PhD, R Nutr*1 & Nasrin Sharifi; PhD2
1 Food Security Research Center, Department. of Clinical Nutrition, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran.
| ARTICLE INFO | ABSTRACT | |
| MINI REVIEW | Background: In recent decades, much interest has been focused on investigating new roles of vitamin D in human body beyond the mineral-ion homeostasis. Methods: By searching medical databases such as PubMed, over 16000 articles were found which have been published since 2000 on novel aspects of vitamin D in health and diseases. Results: Of great interest was the effects of vitamin D on decreasing the risk of several chronic illnesses, including common cancers, autoimmune, infectious, and cardiovascular diseases. In this review, the new roles of vitamin D that have recently been investigated were addressed. Conclusions: Due to the vast prevalence of vitamin D deficiency worldwide, it seems that time has come to conduct well-designed clinical trials and meta-analysis to explore the effectiveness of vitamin D supplementation in treatment of common diseases. Finally, the progression in cellular and molecular methods and technology will shed new lights on vitamin D roles in health and disease. Keywords: Vitamin D; Antioxidant; Inflammation; Gastrointestinal diseases; Depression |
|
| Article history: Received: 11 Feb 2017 Revised: 11 Mar 2017 Accepted: 22 Apr 2017 |
||
| *Corresponding author: r_amani@mail.mui.ac.ir Food Security Research Center, Deptartment of Clinical Nutrition, School of Nutrition and Food, Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. Postal code: 8916188637 Tel: +98 916 313 9856 |
Vitamin D and chronic inflammation
Recently, non-calcemic functions of vitamin D, especially anti-inflammatory and immunomodulatory effects have attracted much attention. The beneficial effect of vitamin D intake on high-sensitive C-reactive protein (hs-CRP) was investigated in patients with non-alcoholic fatty liver disease (NAFLD) (Figure 1) (Sharifi et al., 2014).It has been found that 1,25(OH)2D inhibits the T-helper1 response and may promote T-helper2 response, in other words, it could reduce production of inflammatory cytokines and induce anti-inflammatory response (Cantorna et al., 2004).
Recently, non-calcemic functions of vitamin D, especially anti-inflammatory and immunomodulatory effects have attracted much attention. The beneficial effect of vitamin D intake on high-sensitive C-reactive protein (hs-CRP) was investigated in patients with non-alcoholic fatty liver disease (NAFLD) (Figure 1) (Sharifi et al., 2014).It has been found that 1,25(OH)2D inhibits the T-helper1 response and may promote T-helper2 response, in other words, it could reduce production of inflammatory cytokines and induce anti-inflammatory response (Cantorna et al., 2004).
Antioxidant effects of vitamin D
The antioxidant role of vitamin D was initially proposed by Wiseman in 1993; it was sown that vitamin D3 and its active form 1,25(OH)2D3 inhibited iron dependent liposomal lipid peroxidation (Wiseman, 1993). The structural similarity of vitamin D compounds to cholesterol and ergosterol suggested for their membrane antioxidant ability (Wiseman, 1993). For the first time, it was found that improving vitamin D status in NAFLD patients could effectively reduce serum levels of Malondialdehyde (MDA) (Figure 2) (Sharifi et al., 2014).
The antioxidant role of vitamin D was initially proposed by Wiseman in 1993; it was sown that vitamin D3 and its active form 1,25(OH)2D3 inhibited iron dependent liposomal lipid peroxidation (Wiseman, 1993). The structural similarity of vitamin D compounds to cholesterol and ergosterol suggested for their membrane antioxidant ability (Wiseman, 1993). For the first time, it was found that improving vitamin D status in NAFLD patients could effectively reduce serum levels of Malondialdehyde (MDA) (Figure 2) (Sharifi et al., 2014).
It was reported in recent clinical studies on pregnant women that vitamin D supplementation could increase the serum total antioxidant capacity and glutathione levels (Asemi et al., 2013). However, no association was found between 25(OH)D levels and activities of serum antioxidant enzymes in the study that assessed the relation between serum vitamin D levels and body antioxidant status in ischemic stroke patients (Afshari et al., 2015).
Vitamin D and gastrointestinal diseases
Cumulative evidence has implicated the roles of vitamin D deficiency in increasing susceptibility to various gastrointestinal (GI) disorders, including colorectal disease, inflammatory bowel diseases (IBD), and irritable bowel syndrome (IBS) (Ferguson et al., 2016). A high risk of IBD has been associated with deficient or insufficient levels of vitamin D, unhealthy lifestyle, as well as presence of vitamin D related genetic polymorphisms (Basson, 2014). IBS is also a functional GI disorder. In this regard, it was demonstrated for the first time that supplementation with 50,000 IU vitamin D3 every 14 days for 6 months improves the quality of life and clinical symptoms of patients with IBS (Abbasnezhad et al., 2016).
Vitamin D and depression
Vitamin D modulates the hypothalamic-pituitary-adrenal axis, regulating adrenalin, noradrenaline, and dopamine production through vitamin D receptors (VDRs) in the adrenal cortex and protects against the depletion of dopamine and serotonin centrally (Spedding, 2014). Therefore, a biological plausibility has been established for vitamin D effect on depression. Efficacy of vitamin D supplements in depression is controversial, awaiting further literature analysis. Premenstrual syndrome (PMS) is a condition with episodes of physical and psychological signs (Freeman, 2003). Based on the possible roles mentioned above, it seems that vitamin D status is associated with PMS severity. However, there are a limited number of studies assessing the association of vitamin D with this condition. Thus, a cross-sectional study was designed to compare the nutritional status of vitamin D in young students affected by PMS with those of normal participants. The results, however, showed no significant differences in serum levels of vitamin D between the two groups (Saeedian Kia et al., 2015). Further studies will reveal more facts in this area.
Conclusions
In summary, vitamin D may exert important roles in prevention and treatment of many chronic diseases. As a result, it is necessary to maintain the sufficient serum levels of vitamin D among community members through food fortification and supplementation.
Due to the vast prevalence of vitamin D deficiency worldwide, it seems that time has come to conduct well-designed clinical trials and meta-analysis to explore the effectiveness of vitamin D supplementation in treatment of common diseases.
Finally, the progression in cellular and molecular methods and technology will shed new lights on vitamin D roles in health and disease.
Cumulative evidence has implicated the roles of vitamin D deficiency in increasing susceptibility to various gastrointestinal (GI) disorders, including colorectal disease, inflammatory bowel diseases (IBD), and irritable bowel syndrome (IBS) (Ferguson et al., 2016). A high risk of IBD has been associated with deficient or insufficient levels of vitamin D, unhealthy lifestyle, as well as presence of vitamin D related genetic polymorphisms (Basson, 2014). IBS is also a functional GI disorder. In this regard, it was demonstrated for the first time that supplementation with 50,000 IU vitamin D3 every 14 days for 6 months improves the quality of life and clinical symptoms of patients with IBS (Abbasnezhad et al., 2016).
Vitamin D and depression
Vitamin D modulates the hypothalamic-pituitary-adrenal axis, regulating adrenalin, noradrenaline, and dopamine production through vitamin D receptors (VDRs) in the adrenal cortex and protects against the depletion of dopamine and serotonin centrally (Spedding, 2014). Therefore, a biological plausibility has been established for vitamin D effect on depression. Efficacy of vitamin D supplements in depression is controversial, awaiting further literature analysis. Premenstrual syndrome (PMS) is a condition with episodes of physical and psychological signs (Freeman, 2003). Based on the possible roles mentioned above, it seems that vitamin D status is associated with PMS severity. However, there are a limited number of studies assessing the association of vitamin D with this condition. Thus, a cross-sectional study was designed to compare the nutritional status of vitamin D in young students affected by PMS with those of normal participants. The results, however, showed no significant differences in serum levels of vitamin D between the two groups (Saeedian Kia et al., 2015). Further studies will reveal more facts in this area.
Conclusions
In summary, vitamin D may exert important roles in prevention and treatment of many chronic diseases. As a result, it is necessary to maintain the sufficient serum levels of vitamin D among community members through food fortification and supplementation.
Due to the vast prevalence of vitamin D deficiency worldwide, it seems that time has come to conduct well-designed clinical trials and meta-analysis to explore the effectiveness of vitamin D supplementation in treatment of common diseases.
Finally, the progression in cellular and molecular methods and technology will shed new lights on vitamin D roles in health and disease.
References
Abbasnezhad A, et al. 2016. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol & Motility. 28 (10): 1533-1544.
Afshari L, Amani R, Soltani F, Haghighizadeh MH & Afsharmanesh MR 2015. The relation between serum Vitamin D levels and body antioxidant status in ischemic stroke patients: A case-control study. Advanced biomedical research. 4: 213.
Asemi Z, Samimi M, Tabassi Z, Shakeri H & Esmaillzadeh A 2013. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. Journal of Nnutrition. 143 (9): 1432-1438.
Basson A 2014. Vitamin D and Crohn's disease in the adult patient: a review. Journal of parenteral and enteral nutrition. 38 (4): 438-458.
Cantorna MT, Zhu Y, Froicu M & Wittke A 2004. Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. American journal of clinical nutrition. 80 (6): 1717S-1720S.
Ferguson LR, Laing B, Marlow G & Bishop K 2016. The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: Focus on genetic and genomic technologies. Molecular nutrition & food research. 60 (1): 119-133.
Freeman EW 2003. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 28 (supple 3): 25-37.
Saeedian Kia A, Amani R & Cheraghian B 2015. The association between the risk of premenstrual syndrome and vitamin D, Calcium, and magnesium status among University students: A case control study. Health promotion perspectives. 5 (3): 225-230.
Sharifi N, Amani R, Hajiani E & Cheraghian B 2014. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 47 (1): 70-80.
Spedding S 2014. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 6 (4): 1501-1518.
Wiseman H 1993. Vitamin D is a membrane antioxidant Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. Federation of European biochemical societies (FEBS) letters. 326 (1): 285-288.
Afshari L, Amani R, Soltani F, Haghighizadeh MH & Afsharmanesh MR 2015. The relation between serum Vitamin D levels and body antioxidant status in ischemic stroke patients: A case-control study. Advanced biomedical research. 4: 213.
Asemi Z, Samimi M, Tabassi Z, Shakeri H & Esmaillzadeh A 2013. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. Journal of Nnutrition. 143 (9): 1432-1438.
Basson A 2014. Vitamin D and Crohn's disease in the adult patient: a review. Journal of parenteral and enteral nutrition. 38 (4): 438-458.
Cantorna MT, Zhu Y, Froicu M & Wittke A 2004. Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. American journal of clinical nutrition. 80 (6): 1717S-1720S.
Ferguson LR, Laing B, Marlow G & Bishop K 2016. The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: Focus on genetic and genomic technologies. Molecular nutrition & food research. 60 (1): 119-133.
Freeman EW 2003. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology. 28 (supple 3): 25-37.
Saeedian Kia A, Amani R & Cheraghian B 2015. The association between the risk of premenstrual syndrome and vitamin D, Calcium, and magnesium status among University students: A case control study. Health promotion perspectives. 5 (3): 225-230.
Sharifi N, Amani R, Hajiani E & Cheraghian B 2014. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 47 (1): 70-80.
Spedding S 2014. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 6 (4): 1501-1518.
Wiseman H 1993. Vitamin D is a membrane antioxidant Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. Federation of European biochemical societies (FEBS) letters. 326 (1): 285-288.
Type of article: review article |
Subject:
public specific
Received: 2017/02/11 | Published: 2017/08/1 | ePublished: 2017/08/1
Received: 2017/02/11 | Published: 2017/08/1 | ePublished: 2017/08/1
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
